Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | CES1 | P23141 | 6/20 | 0.58 |
| ▸ | CES2 | O00748 | 5/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | DAO | P14920 | 1/20 | 0.55 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.55 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | PARP1 | P09874 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2098567 | 0.89 | TDP1 (0.56) | TDP1L3MBTL1CES1CES2LMNA | |
| SCHEMBL9578308 | 0.89 | TDP1 (0.56) | TDP1L3MBTL1CES1CES2LMNA | |
| SCHEMBL7105558 | 0.85 | TDP1 (0.54) | TDP1L3MBTL1CES1CES2LMNA | |
| SCHEMBL14512285 | 0.85 | TDP1 (0.52) | TDP1L3MBTL1CES1CES2LMNA | |
| SCHEMBL600051 | 0.85 | TDP1 (0.52) | TDP1L3MBTL1CES1CES2LMNA | |
| SCHEMBL2853917 | 0.85 | TDP1 (0.52) | TDP1L3MBTL1CES1CES2LMNA | |
| SCHEMBL27491745 | 0.85 | TDP1 (0.52) | TDP1L3MBTL1CES1CES2LMNA | |
| SCHEMBL31412096 | 0.83 | TDP1 (0.50) | TDP1L3MBTL1CES1CES2LMNA | |
| SCHEMBL29251170 | 0.83 | TDP1 (0.50) | TDP1L3MBTL1CES1CES2LMNA | |
| SCHEMBL11607787 | 0.83 | TDP1 (0.50) | TDP1L3MBTL1CES1CES2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 544 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6288155-B1 | CONTAINING DOLOMITE COMPOUND AND ZINC SALT OF AN ORGANIC ACID | AJINOMOTO CO., INC. (JP) | 2001-09-11 | — | — | US | claimed |
| EP-0108023-B1 | PROCESS FOR THE STABILIZATION OF VINYL CHLORIDE POLYMERS | RHONE-POULENC CHIMIE (FR) | 1986-12-17 | — | — | EP | claimed |
| EP-0108023-A1 | Process for the stabilization of vinyl chloride polymers | RHONE-POULENC CHIMIE (FR) | 1984-05-09 | — | — | EP | claimed |
| US-20260145365-A1 | METHOD AND DEVICE FOR PRODUCING A STABILIZER COMPOSITION IN GRANULATE FORM AND AN ACCORDINGLY PRODUCED STABILIZER COMPOSITION | AKDENIZ CHEMSON ADDITIVES A.G. (AT) | 2026-05-28 | — | — | US | disclosed |
| EP-4605200-A1 | METHOD AND DEVICE FOR PRODUCING A STABILIZER COMPOSITION IN GRANULATE FORM AND AN ACCORDINGLY PRODUCED STABILIZER COMPOSITION | Akdeniz Chemson Additives AG (AT) | 2025-08-27 | — | — | EP | disclosed |
| CN-120076911-A | Method and device for producing a stabilizer composition in particulate form and stabilizer composition produced thereby | 阿登尼斯开米森添加剂股份公司 | 2025-05-30 | — | — | CN | disclosed |
| WO-2025050647-A1 | IONIZABLE CATIONIC LIPID COMPOUNDS AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 晟迪生物医药(苏州)有限公司 | 2025-03-13 | — | — | WO | disclosed |
| WO-2024256407-A1 | METHOD FOR TREATING HALOGENATED POLYMERS | BAERLOCHER GMBH (DE) | 2024-12-19 | — | — | WO | disclosed |
| EP-4477694-A1 | METHOD FOR TREATING HALOGENATED POLYMERS | Baerlocher GmbH (DE) | 2024-12-18 | — | — | EP | disclosed |
| US-20240165866-A1 | METHOD FOR PRODUCING A STABILISER COMPOSITION FOR A POLYMER, AND STABILISER COMPOSITION PRODUCED USING SAID METHOD | AKDENIZ CHEMSON ADDITIVES AG (AT) | 2024-05-23 | — | — | US | disclosed |
| WO-2024083304-A1 | METHOD AND DEVICE FOR PRODUCING A STABILIZER COMPOSITION IN GRANULATE FORM AND AN ACCORDINGLY PRODUCED STABILIZER COMPOSITION | AKDENIZ CHEMSON ADDITIVES A.G. (AT) | 2024-04-25 | — | — | WO | disclosed |
| EP-0035268-A1 | Chlorinated organic compounds having their resistance to deterioration enhanced by 1,3-dicarbonyl compounds | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1981-09-09 | — | — | EP | disclosed |
| US-4282141-A | DISCOLORATION INHIBITION FOR VINYL CHLORIDE POLYMERS | ARGUS CHEMICAL CORPORATION (US) | 1981-08-04 | — | — | US | disclosed |
| US-4252698-A | A OVERBASED SULFONATE OR PHENOLATE, AND A 1,3-DIKETONE FOR VINYL CHLORIDE POLYMERS | ARGUS CHEMICAL CORPORATION (US) | 1981-02-24 | — | — | US | disclosed |
| US-4244848-A | HEAT RESISTANT STABILIZERS COMPRISING AT LEAST ONE ZINC, DIALKYLTIN, ALKALI METAL OR ALKALINE EARTH METAL ORGANIC PHOSPHATE ESTER SALT AND AT LEAST ONE B-DIKETONE | ARGUS CHEMICAL CORPORATION (US) | 1981-01-13 | — | — | US | disclosed |
| US-4224218-A | Stabilized vinyl chloride polymer comprising a metal mono-organic phosphite | ARGUS CHEMICAL CORPORATION (US) | 1980-09-23 | — | — | US | disclosed |
| US-4224203-A | Vinyl chloride polymer stabilizer comprising a metal organophosphonate | ARGUS CHEMICAL CORPORATION (US) | 1980-09-23 | — | — | US | disclosed |
| US-4102839-A | METAL SALT OF A CARBOXYLIC ACID AND A DIKETONE OR KETO-ALDEHYDE | RHONE-POULENC INDUSTRIES (FR) | 1978-07-25 | — | — | US | disclosed |
| US-4020073-A | Process for O-acylating thallus salts of 2-pyridone | TAYLOR EDWARD C | 1977-04-26 | — | — | US | disclosed |
| US-3947488-A | O-Acylation using organothallium compounds | TAYLOR EDWARD C | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260145365-A1 | METHOD AND DEVICE FOR PRODUCING A STABILIZER COMPOSITION IN GRANULATE FORM AND AN ACCORDINGLY PRODUCED STABILIZER COMPOSITION | GRN, IL36G, GMNN | TDP1 3313/4885L3MBTL1 3102/4885CES1 4642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.